Ipca Laboratories Ltd — Quarterly Results & Earnings

₹1601.20

+1.02%

Profit Growth YoY41.49%Latest quarter

Sales Growth YoY8.56%Latest quarter

Sales CAGR 5Y14.01%5 year compound

Profit CAGR 5Y7.24%5 year compound

📋

Quarterly Performance

YoY Profit Growth+41.49%

🔥 Exceptional growth

YoY Sales Growth+8.56%

📈 Moderate growth

OPM 5Y Average

Operating profit margin

20.22%

EPS Growth 5Y

7.16%

Interest Coverage

Higher = safer debt servicing

20.38

ROE

12.75%

ROCE

14.72%

💡

Growth Analysis

Ipca Laboratories Ltd reported YoY profit growth of 41.49% and revenue growth of 8.56% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 14.01% and profits at 7.24% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Ipca Laboratories Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.